Increased expression of CYP24A1 correlates with advanced stages of prostate cancer and can cause resistance to vitamin D3-based therapies.
| Image |  |
|---|---|
| Description | scientific article published on 30 September 2013 |
| Author/s | |
| Publication date | September 30, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |